Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D, Bi N, Zhang T, Zhou Z, Xiao Z, Liang J, Chen D, Hui Z, Lv J, Wang X, Wang X, Deng L, Wang W, Wang J, Wang C, Lu X, Xu K, Wu L, Xue W, Feng Q, Wang L. Wang D, et al. Among authors: wu l. Radiat Oncol. 2019 Jun 13;14(1):106. doi: 10.1186/s13014-019-1259-3. Radiat Oncol. 2019. PMID: 31196118 Free PMC article.
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer.
Zhang T, Xue W, Wang D, Xu K, Wu L, Wu Y, Zhou Z, Chen D, Feng Q, Liang J, Xiao Z, Hui Z, Lv J, Wang X, Deng L, Wang W, Liu W, Wang J, Zhai Y, Wang J, Bi N, Wang L. Zhang T, et al. Among authors: wu y, wu l. Radiother Oncol. 2021 Mar;156:244-250. doi: 10.1016/j.radonc.2020.12.039. Epub 2021 Jan 5. Radiother Oncol. 2021. PMID: 33418003
Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer.
Yang Y, Wang J, Wang J, Zhao X, Zhang T, Yang Y, Pang J, Ou Q, Wu L, Xu X, Xu K, Zhao J, Bai N, Yang P, Wang S, Wang L, Bi N. Yang Y, et al. Among authors: wu l. Cancer Lett. 2024 Feb 1;582:216569. doi: 10.1016/j.canlet.2023.216569. Epub 2023 Dec 13. Cancer Lett. 2024. PMID: 38101608
The time-series behavior of systemic inflammation-immune status in predicting survival of locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Zhang T, Wang J, Wang D, Xu K, Wu L, Wang X, Wang W, Deng L, Liang J, Lv J, Hui Z, Zhou Z, Feng Q, Xiao Z, Chen D, Wang J, Wang L, Bi N. Zhang T, et al. Among authors: wu l. J Natl Cancer Cent. 2021 Nov 10;2(1):33-40. doi: 10.1016/j.jncc.2021.11.003. eCollection 2022 Mar. J Natl Cancer Cent. 2021. PMID: 39035216 Free PMC article.
32,750 results
You have reached the last available page of results. Please see the User Guide for more information.